January 25, 2023
Devising a smarter way to treat brain tumors
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
Tag: Shawn Hingtgen
October 6, 2021
Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma
Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness.
February 23, 2021
Ovarian Cancer News Today: She ROCKS Raises $100K to Support Early Work Into Stem Cell Therapy
February 8, 2021
She ROCKS reaches $1 million milestone to support ovarian cancer research and care
She ROCKS supports the work of UNC Lineberger’s Victoria Bae-Jump, MD, and her work focusing on advancing the prevention, early detection and treatment of ovarian cancer.
August 27, 2018
Stem cells show promise as drug delivery tool for childhood brain cancer
UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children.